Vistin Pharma ASA (OSL:VISTN)

Norway flag Norway · Delayed Price · Currency is NOK
22.90
+0.10 (0.44%)
At close: Oct 2, 2025
0.44%
Market Cap1.02B
Revenue (ttm)452.25M
Net Income (ttm)76.10M
Shares Out44.34M
EPS (ttm)1.72
PE Ratio13.34
Forward PEn/a
Dividend1.25 (5.46%)
Ex-Dividend DateJun 4, 2025
Volume8,508
Average Volume10,312
Open23.30
Previous Close22.80
Day's Range22.80 - 23.30
52-Week Range22.10 - 28.50
Beta0.63
RSI41.61
Earnings DateOct 31, 2025

About Vistin Pharma ASA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is based in Oslo, Norway. [Read more]

Sector Healthcare
Founded 1969
Employees 75
Stock Exchange Oslo Børs
Ticker Symbol VISTN
Full Company Profile

Financial Performance

In 2024, Vistin Pharma ASA's revenue was 429.50 million, a decrease of -2.01% compared to the previous year's 438.33 million. Earnings were 62.75 million, an increase of 37.62%.

Financial Statements

News

There is no news available yet.